Viruses are able to redirect the functioning of cells in order to infect them. Inspired by their mode of action, scientists from the CNRS and Université de Strasbourg have designed a “chemical virus” that can cross the double lipid layer that surrounds cells, and then disintegrate in the intracellular medium in order to release active compounds.
To achieve this, the team used two polymers they had designed, which notably can self-assemble or dissociate, depending on the conditions. This work, the result of collaborative efforts by chemists, biologists and biophysicists, is published in the 1st September issue of Angewandte Chemie International Edition.
Biotechnological advances have offered access to a wealth of compounds with therapeutic potential. Many of these compounds are only active inside human cells but remain unusable because the lipid membrane surrounding these cells is a barrier they cannot cross. The challenge is therefore to find transfer solutions that can cross this barrier.
By imitating the ability of viruses to penetrate into cells, chemists in the Laboratoire de Conception et Application de Molécules Bioactives (CNRS/Université de Strasbourg) sought to design particles capable of releasing macromolecules that are only active inside cells. To achieve this, these particles must comply with several, often contradictory, constraints. They must remain stable in the extracellular medium, they must be able to bind to the cells so that they be internalized, but they must be more fragile inside the cells so that they can release their content.
Using two polymers designed by the team, the scientists succeeded in creating a “chemical virus” that meets the conditions necessary for the direct delivery of active proteins into cells.
In practice, the first polymer (pGi-Ni2+) serves as a substrate for the proteins that bind to it. The second, recently patented polymer (?PEI), encapsulates this assembly thanks to its positive charges, which bind to the negative charges of pGi-Ni2+. The particles obtained (30-40 nanometers in diameter) are able to recognize the cell membrane and bind to it. This binding activates a cellular response: the nanoparticle is surrounded by a membrane fragment and enters the intracellular compartment, called the endosome. Although they remain stable outside the cell, the assemblies are attacked by the acidity that prevails within this new environment. Furthermore, this drop in pH allows the ?PEI to burst the endosome, releasing its content of active compounds.
Thanks to this assembly, the scientists were able to concentrate enough active proteins within the cells to achieve a notable biological effect. Thus by delivering a protein called caspase 3 into cancer cell lines, they succeeded in inducing 80% cell death1.
The in vitro results are encouraging, particularly since this “chemical virus” only becomes toxic at a dose ten times higher than that used during the study. Furthermore, preliminary results in the mouse have not revealed any excess mortality. However, elimination by the body of the two polymers remains an open question. The next stage will consist in testing this method in-depth and in vivo, in animals. In the short term, this system will serve as a research tool to vectorize2 recombinant and/or chemically modified proteins into cells. In the longer term, this work could make it possible to apply pharmaceutical proteins to intracellular targets and contribute to the development of innovative drugs.
Read more: Imitating viruses to deliver drugs to cells
The Latest on: Imitating viruses to deliver drugs to cells
via Google News
The Latest on: Imitating viruses to deliver drugs to cells
- If you want to ban fetal tissue research, sign a pledge to refuse its benefitson January 24, 2020 at 4:04 am
Immediately, important work at two NIH-supported labs in Montana and California that are fighting the AIDS epidemic stopped because they were testing new medications against HIV using mice with human ...
- Researchers uncover mechanism for how common gene therapy vectors enter cellson January 23, 2020 at 8:59 am
Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector ... lock' to the cell. GPR108 is required for most AAVs, ...
- Precision BioSciences: Incentivised To Deliver, But Outlook Not Promisingon January 22, 2020 at 5:35 pm
Precision has a lot riding on its ability to deliver promising drug candidates for CAR-T therapy having secured a potentially lucrative deal with French pharmaceutical Servier Laboratories. By the ...
- Targovax plans checkpoint combo trial after posting early data on oncolytic viruson January 22, 2020 at 4:05 am
The response rate was lower in the ONCOS-102 arm than in the control cohort, but Targovax saw positives elsewhere, leading it to outline plans to pair the drug with a checkpoint inhibitor ...
- Potential Parkinson's treatment effectively targets a specific group of brain cellson January 21, 2020 at 10:33 pm
Scientists have discovered that a non-invasive technique which could one day be used to treat Parkinson's disease, can successfully target a highly specific group of brain cells which ... used a ...
- Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockadeon January 15, 2020 at 5:25 pm
1 Drug Discovery ... Oncolytic viruses, which kill cancer cells, have received increasing attention in recent years as the field has advanced toward biological and immune-based approaches to fighting ...
- New virus-inspired method to deliver drugs to brain developed: Studyon October 12, 2019 at 7:00 am
The researchers, including those from Newcastle University in the UK, synthesised and modified components from a virus that targets the brain , a bacteriophage fd to deliver drugs across the BBB.
- Plant-made virus shells could deliver drugs directly to cancer cellson February 15, 2019 at 3:06 pm
In the journal ACS Nano, researchers report they have harnessed this well-honed ability — minus the part that makes us sick — to develop virus-like nanoparticles to deliver drugs straight to affected ...
- Nanoscale Virus Altered to Deliver Peptide Drugs to Cellson January 10, 2018 at 1:17 am
nanoscale devices that may be capable of supplying drugs to cells. Nicole Thadani (left) and Junghae Suh of Rice University have developed programmable adeno-associated viruses that may be used to ...
- Plant-made virus shells could deliver drugs directly to cancer cellson February 15, 2017 at 6:47 am
Viruses are extremely efficient at targeting and delivering cargo to cells. Researchers report they have harnessed this well-honed ability -- minus the part that makes us sick -- to develop virus ...
via Bing News